BioC3 is a French biotech startup that have developed an innovative bio-based strategy, to allow the production of a platform molecule: DHAP and a co-product, Methylglyoxal This renewable DHAP can be easily derived into phosphorylated sugars, which finds applications in chemistry, pharmaceutical and cosmetic industry.
The innovative process allows BioC3 to compete with chemical production of DHAP and derivatives with a bio-based strategy.

BioC3

412 lot les hauts de Rebigue
31320 Rebigue I France
For any requests, please fill in the form below. We will get back to you as soon as possible.